In the 5th edition of the annual Inhaled & Nasal Biologics | DNA Forum, the conference will serve as a platform to explore the latest research and best strategies in pulmonary and intranasal biologic and DNA drug development. Featuring leading industry experts sharing insights and real-world case studies, the programme will examine innovative formulation and delivery technologies, as well as the approaches used to address key development challenges.